BDX - BECTON DICKINSON & CO

QQQ $ 438.06 $ 1.11 (0.25 %)

DIA $ 387.14 $ -1.37 (-0.35 %)

SPY $ 514.12 $ 0.35 (0.07 %)

TLT $ 89.78 $ -0.10 (-0.11 %)

GLD $ 214.96 $ -0.08 (-0.04 %)

Previous Close

$ 234.68

Open

$ 236.50

Bid

$ 235.95 x 100

Ask

$ 237.31 x 100

Day's Range

$ 235.85 - $ 237.85

52 Week Range

$ 228.00 - $ 284.02

Volume

1,722,353

Average Volume

Market Cap

67.82B

Beta (5Y Monthly)

$ 0.46

PE Ratio (TTM)

$ 51.46

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.02)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	02-01-2024	12-31-2023	10-Q
3	11-21-2023	09-30-2023	10-K
4	08-03-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	02-02-2023	12-31-2022	10-Q
7	11-22-2022	09-30-2022	10-K
8	08-04-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	02-03-2022	12-31-2021	10-Q
11	11-24-2021	09-30-2021	10-K
12	08-05-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	02-04-2021	12-31-2020	10-Q
15	11-25-2020	09-30-2020	10-K
16	08-06-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	02-06-2020	12-31-2019	10-Q
19	11-27-2019	09-30-2019	10-K
20	08-06-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	02-05-2019	12-31-2018	10-Q
23	11-21-2018	09-30-2018	10-K
24	08-02-2018	06-30-2018	10-Q
25	05-03-2018	03-31-2018	10-Q
26	02-06-2018	12-31-2017	10-Q
27	11-22-2017	09-30-2017	10-K
28	08-03-2017	06-30-2017	10-Q
29	05-02-2017	03-31-2017	10-Q
30	02-02-2017	12-31-2016	10-Q
31	11-23-2016	09-30-2016	10-K
32	08-04-2016	06-30-2016	10-Q
33	05-06-2016	03-31-2016	10-Q
34	02-05-2016	12-31-2015	10-Q
35	11-25-2015	09-30-2015	10-K
36	08-06-2015	06-30-2015	10-Q
37	05-08-2015	03-31-2015	10-Q
38	02-06-2015	12-31-2014	10-Q
39	11-26-2014	09-30-2014	10-K
40	08-04-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Barclays Maintains Overweight on Becton Di...
05/06/2024 15:10:49

Barclays analyst Travis Steed maintains Becton Dickinson (NYSE:BDX) with a Overweight and raises the price target from $305 ...

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
05/03/2024 17:35:23

becton--dickinson-is-well-on-its-way-to-achieving-2025-commitments-analyst-optimistic-on-outlook

Becton & Dickinson 'Is Well On Its Way To ...
05/02/2024 16:16:40

BD reports Q2 sales of $5.04 billion, up 4.6% Y/Y. BD Medical, Life Sciences, and Interventional segments show growth. Guidance...

Becton, Dickinson shares are trading highe...
05/02/2024 11:09:19

Becton, Dickinson Q2 2024 Adj EPS $3.17 Be...
05/02/2024 10:33:26

Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $3.17 per share which beat the analyst consensus estimate of $2.97 ...

looking-into-becton-dickinsons-recent-short-interest

Looking Into Becton Dickinson's Recent Sho...
04/29/2024 16:45:27

Becton, Dickinson Announced Global Commerc...
04/05/2024 10:49:28

The new BD FACSDiscover S8 Cell Sorters feature BD CellView Image Technology, profiled on the cover of the journal Science in 2...

angiodynamics-resolves-decade-long-patent-litigation-with-becton-dickinson-in-settlement-agreement

AngioDynamics Resolves Decade-Long Patent ...
04/02/2024 12:51:58

AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses...

AngioDynamics Reports Settlement Of All Pa...
04/01/2024 21:32:12

Under the terms of the settlement, BD will grant a license to AngioDynamics under certain of BD's port patents and AngioDyn...

peering-into-becton-dickinsons-recent-short-interest

Peering Into Becton Dickinson's Recent Sho...
03/29/2024 16:45:18

Jim Cramer Says Don't Sell This Beauty Bra...
03/26/2024 12:54:36

On CNBC’s "Mad Money Lightning Round," Jim Cramer sang the praises of Energy Transfer LP (NYSE: ET), which posted bet...

fda-probe-on-china-made-syringes-becton-dickinson-boosts-us-syringe-output-following-concerns

FDA Probe On China-Made Syringes: Becton D...
03/21/2024 17:47:31

BD boosts U.S. production of medical syringes following FDA concerns over Chinese-made syringes. Learn how BD addresses patient...

Becton, Dickinson And Company Raised Domes...
03/21/2024 10:54:16

Becton, Dickinson Announced The Enrollment...
03/04/2024 11:52:15

According to BD, the global, prospective, multi-center, single-arm, non-randomized AGILITY clinical study will include 315 pati...

Dave Hickey to Retire from Becton, Dickins...
02/27/2024 11:52:07

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that Dave Hickey ha...

Peering Into Becton Dickinson's Recent Sho...
02/21/2024 20:15:25

BD Partners with Camtech Health to Increas...
02/21/2024 11:46:25

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced a strategic partner...

Becton Dickinson Stock: A Deep Dive Into A...
02/05/2024 12:00:30

Barclays Maintains Overweight on Becton Di...
02/05/2024 11:57:43

Barclays analyst Travis Steed maintains Becton Dickinson (NYSE:BDX) with a Overweight and raises the price target from $301 ...

medical-device-maker-becton-dickinsons-q1-earnings-heres-why-this-analyst-is-bullish-on-long-term-prospects

Medical Device Maker Becton Dickinson's Q1...
02/01/2024 19:49:40

BD exceeds expectations with Q1 2024 adjusted EPS of $2.68 (vs $2.40 consensus). William Blair maintains a positive outlook, co...